Journal of Literature Pharmacy Sciences

Oksisteroller: Hücresel Etkileri ve Kronik Hastalıklarla İlişkileri
Oxysterols: Cellular Effects and Relations with Chronical Diseases
Neslihan AKSUa, Suna SABUNCUOĞLUa
aFarmakoloji Toksikoloji ABD, Hacettepe Üniversitesi Eczacılık Fakültesi, Ankara, TÜRKİYE
J Lit Pharm Sci. 2019;8(3):225-34
doi: 10.5336/pharmsci.2019-65607
Article Language: TR
Full Text
ÖZET
 Oksisteroller, kolesterolün oksidasyonu sonucu oluşan 27-C'li yan ürünleridir. Farklı kimyasal yapılara sahip çok sayıda oksisterol türevi bulunmaktadır. Kolesterol molekülüne bir oksijenli fonksiyonel grubun çeşitli pozisyonlarda eklenmesi ile oluşan oksisteroller, kolesterol molekülünün yarı ömrünü büyük ölçüde azaltmaktadır. Bu moleküller, kolesterolün vücuttan atılımını artırır ya da suda çözünen safra asitlerinin oksidasyon reaksiyonlarına aracılık eder. Ayrıca, molekülün, lipofilik membranları geçmesine olanak sağlar. Oksisteroller, özellikle steroid yan zincirine oksijen eklenmesiyle kolaylıkla hücrelerden dışarı taşınabilir ve böylece ekstrahepatik kaynaklardan kolesterolün uzaklaştırılmasını kolaylaştırır. Oksisteroller, enzimatik ve enzimatik olmayan yollarla olmak üzere iki farklı yolaktan oluşabilir veya üretilir. Dolaşımda ve dokularda enzimatik yolla oluşan oksisteroller daha fazla bulunmaktadır ve bu türevler vücutta önemli biyolojik faaliyetlerin regülasyonunda görevler almaktadır. Enzimatik olmayan (oto-oksidasyon) yolla oluşan oksisterol türevleri ise patolojik olayların oluşumuna katkıda bulunurlar. Sitotoksik ve pro-apoptotik özellikleri yanı sıra inflamatuar yanıtları indükledikleri ve hücre farklılaşma sürecinde yer almaları nedeniyle ateroskleroz, yaşlanma, Alzheimer ve kanser gibi pek çok hastalığın oluşum mekanizmasında rol oynadıkları belirtilmektedir. Memeli dokularında çok düşük konsantrasyonlarda olduğu belirlenen oksisteroller, pek çok patolojik durumda dokularda yüksek düzeylere ulaşabilmektedir. Bu nedenle, kolesterolün atılım yolaklarında oluşan bu moleküllerin hastalıkların teşhisi ve izlenmesinde biyobelirteç olarak kullanılabileceği düşünülmektedir. Bu çalışmada, pek çok hastalığın patogenezi ile de ilişkilendirilen oksisterollerin biyolojik etkileri ve kronik hastalıklarla ilişkileri ortaya konulmuştur.

Anahtar Kelimeler: Oksisteroller; kolesterol; oto-oksidasyon; kronik hastalık
ABSTRACT
 Oxysterols are with 27-C by-side products formed by oxidation of cholesterol. There are numerous oxysterol derivatives with different chemical structures. Oxysterols formed by the addition of an oxygenated functional group to the cholesterol molecule greatly reduce the half-life of the cholesterol molecule. These molecules increase the excretion of cholesterol or mediate the oxidation reactions of water-soluble bile acids. It allows the molecule to pass through the lipophilic membranes. Oxysterols can be easily transported out of the cells with addition of oxygen to the steroid side chain, thus facilitating the removal of cholesterol from extrahepatic sources. Oxysterols can be formed by two different pathways, enzymatic and non-enzymatic pathways. There are more enzymatic occurring oxysterols in circulation and tissues. Enzymatic occurring oxysterols are involved in the regulation of important biological activity in the body. Oxysterol derivatives which are formed by non-enzymatic (auto-oxidation) pathways contribute to the formation of pathological events. In addition to their cytotoxic and pro-apoptotic properties, they induce inflammatory responses and are involved in the process of cell differentiation and they play a role in the formation of many diseases such as atherosclerosis, aging, Alzheimer and cancer. Oxysterols in very low concentrations in mammalian tissues can reach high levels in tissues in pathological conditions. Therefore, it is thought that these molecules formed in cholesterol's excretion pathways can be used as biomarkers in diagnosing and monitoring diseases. In this review, the biological effects of oxysterols associated with the pathogenesis of many diseases and their relationship with chronic diseases have been demonstrated.

Keywords: Oxysterols; cholesterol; auto-oxidation; chronic disease
REFERENCES:
  1. Aksoy M. Beslenme Biyokimyasi. 2. Baski. Ankara: Hatipoglu Yayinevi; 2008. p.680.
  2. Bjorkhem I, Diczfalusy U, Lutjohann D. Removal of cholesterol from extrahepatic sources by oxidative mechanisms. Curr Opin Lipidol. 1999;10(2):161-5. [Crossref]  [PubMed] 
  3. Leonarduzzi G, Sottero B, Poli G. Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects. J Nutr Biochem. 2002;13(12):700-10. [Crossref] 
  4. Miyoshi N, Iuliano L, Tomono S, Ohshima H. Implications of cholesterol autoxidation products in the pathogenesis of inflammatory diseases. Biochem Biophys Res Commun. 2014;446(3):702-8. [Crossref]  [PubMed] 
  5. Pikuleva IA. Cholesterol-metabolizing cytochromes P450: implications for cholesterol lowering. Expert Opin Drug Metab Toxicol. 2008;4(11):1403-14. [Crossref]  [PubMed]  [PMC] 
  6. Bjorkhem I, Diczfalusy U. Oxysterols: friends, foes, or just fellow passengers? Arterioscler Thromb Vasc Biol. 2002;22(5): 734-42. [Crossref]  [PubMed] 
  7. Smith LL. Cholesterol autoxidation 1981-1986. Chem Phys Lipids. 1987;44(2-4):87-125. [Crossref] 
  8. Smith LL, Johnson BH. Biological activities of oxysterols. Free Radic Biol Med. 1989;7(3): 285-332. [Crossref] 
  9. Luu B, Moog C. Oxysterols: biological activities and physicochemical studies. Biochimie. 1991;73(10):1317-20. [Crossref] 
  10. Smith LL. Review of progress in sterol oxidations: 1987-1995. Lipids. 1996;31(5):453-87. [Crossref]  [PubMed] 
  11. Guardiola F, Codony R, Addis P, Rafecas M, Boatella J. Biological effects of oxysterols: current status. Food Chem Toxicol. 1996;34(2): 193-211. [Crossref] 
  12. Brown AJ, Jessup W. Oxysterols and atherosclerosis. Atherosclerosis. 1999;142(1):1-28. [Crossref] 
  13. Schroepfer GJ Jr. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev. 2000;80(1):361-554. [Crossref]  [PubMed] 
  14. Lyons MA, Brown AJ. 7-Ketocholesterol. Int J Biochem Cell Biol. 1999;31(3-4):369-75. [Crossref] 
  15. Lange Y, Ye J, Strebel F. Movement of 25-hydroxycholesterol from the plasma membrane to the rough endoplasmic reticulum in cultured hepatoma cells. J Lipid Res. 1995;36(5):1092-7.
  16. Jusakul A, Yongvanit P, Loilome W, Namwat N, Kuver R. Mechanisms of oxysterol-induced carcinogenesis. Lipids Health Dis. 2011;10(1): 44. [Crossref]  [PubMed]  [PMC] 
  17. Russell DW. Nuclear orphan receptors control cholesterol catabolism. Cell. 1999;97(5):539-42. [Crossref] 
  18. Repa JJ, Mangelsdorf DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol. 2000;16(1):459-81. [Crossref]  [PubMed] 
  19. Chiang JY, Kimmel R, Stroup D. Regulation of cholesterol 7?-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXR?). Gene. 2001;262(1):257-65. [Crossref] 
  20. Princen HM, Post SM, Twisk J. Regulation of bile acid biosynthesis. Curr Pharm Design. 1997;3:59-64.
  21. Bjorkhem I. Mechanism of degradation of the steroid side chain in the formation of bile acids. J Lipid Res. 1992;33(4):455-71.
  22. Lund EG, Guileyardo JM, Russell DW. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci U S A. 1999;96(13):7238-43. [Crossref]  [PubMed]  [PMC] 
  23. Bjorkhem I, Lutjohann D, Diczfalusy U, Stahle L, Ahlborg G, Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res. 1998;39(8):1594-600.
  24. Lutjohann D, Breuer O, Ahlborg G, Nennesmo I, Siden A, Diczfalusy U, et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci U S A. 1996;93(18):9799-804. [Crossref]  [PubMed]  [PMC] 
  25. Bjorkhem I, Lutjohann D, Breuer O, Sakinis A, Wennmalm A. Importance of a novel oxidative mechanism for elimination of brain cholesterol turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. J Biol Chem. 1997;272(48):30178-84. [Crossref]  [PubMed] 
  26. Bjorkhem I, Andersson U, Ellis E, Alvelius G, Ellegard L, Diczfalusy U, et al. From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24s-hydroxycholesterol (cerebrosterol) in humans. J Biol Chem. 2001;276(40):37004-10. [Crossref]  [PubMed] 
  27. Bodin K, Bretillon L, Aden Y, Bertilsson L, Broome U, Einarsson C, et al. Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterolin humans: evidence for involvement of cytochrome P450 3A4. J Biol Chem. 2001;276(42):38685-9. [Crossref]  [PubMed] 
  28. Lund EG, Kerr TA, Sakai J, Li WP, Russell DW. cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J Biol Chem. 1998;273(51):34316-27. [Crossref]  [PubMed] 
  29. Russell DW. Oxysterol biosynthetic enzymes. Biochim Biophys Acta. 2000;1529(1-3):126-35. [Crossref] 
  30. Nelson JA, Steckbeck SR, Spencer TA. Biosynthesis of 24, 25-epoxycholesterol from squalene 2, 3; 22, 23-dioxide. J Biol Chem. 1981;256(3):1067-8.
  31. Zhang Z, Li D, Blanchard DE, Lear SR, Erickson SK, Spencer TA. Key regulatory oxysterols in liver: analysis as ?4-3-ketone derivatives by HPLC and response to physiological perturbations. J Lipid Res. 2001;42(4): 649-58.
  32. Gupta A, Sexton RC, Rudney H. Modulation of regulatory oxysterol formation and low density lipoprotein suppression of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity by ketoconazole. A role for cytochrome P-450 in the regulation of HMG-CoA reductase in rat intestinal epithelial cells. J Biol Chem. 1986;261(18):8348-56.
  33. Spencer TA, Gayen AK, Phirwa S, Nelson JA, Taylor F, Kandutsch A, et al. 24(S), 25-Epoxycholesterol. Evidence consistent with a role in the regulation of hepatic cholesterogenesis. J Biol Chem. 1985;260(25):13391-4.
  34. Olkkonen VM, Beaslas O, Nissila E. Oxysterols and their cellular effectors. Biomolecules. 2012;2(1):76-103. [Crossref]  [PubMed]  [PMC] 
  35. Lordan S, Mackrill JJ, O'Brien NM. Oxysterols and mechanisms of apoptotic signaling: implications in the pathology of degenerative diseases. J Nutr Biochem. 2009;20(5):321-36. [Crossref]  [PubMed] 
  36. Zhang HF, Basra HJ, Steinbrecher UP. Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages. J Lipid Res. 1990;31(8):1361-9.
  37. Griffiths WJ, Abdel-Khalik J, Crick PJ, Yutuc E, Wang Y. New methods for analysis of oxysterols and related compounds by LC-MS. J Steroid Biochem Mol Biol. 2016;162:4-26. [Crossref]  [PubMed] 
  38. De Boussac H, Alioui A, Viennois E, Dufour J, Trousson A, Vega A, et al. Oxysterol receptors and their therapeutic applications in cancer conditions. Expert Opin Ther Targets. 2013;17(9):1029-38. [Crossref]  [PubMed] 
  39. Sabuncuoglu S, Oztas Y. Oxysterols and their metabolic roles beyond cholesterol: a reappraisal. Acta Medica. 2014;45(1):75-9.
  40. Kandutsch A, Shown EP. Assay of oxysterol-binding protein in a mouse fibroblast, cell-free system. Dissociation constant and other properties of the system. J Biol Chem. 1981;256(24):13068-73.
  41. Jaworski CJ, Moreira E, Li A, Lee R, Rodriguez IR. A family of 12 human genes containing oxysterol-binding domains. Genomics. 2001;78(3):185-96. [Crossref]  [PubMed] 
  42. Poli G, Biasi F, Leonarduzzi G. Oxysterols in the pathogenesis of major chronic diseases. Redox Biol. 2013;1(1):125-30. [Crossref]  [PubMed]  [PMC] 
  43. Sevanian A, Peterson A. Cholesterol epoxide is a direct-acting mutagen. Proc Natl Acad Sci U S A. 1984;81(13):4198-202. [Crossref]  [PubMed]  [PMC] 
  44. Garcia-Cruset S, Carpenter KL, Guardiola F, Stein BK, Mitchinson MJ. Oxysterol profiles of normal human arteries, fatty streaks and advanced lesions. Free Radic Res. 2001;35(1): 31-41. [Crossref]  [PubMed] 
  45. Lo WB, Black HS. Formation of cholesterol-derived photoproducts in human skin. J Invest Dermatol. 1972;58(5):278-83. [Crossref]  [PubMed] 
  46. Liao PL, Cheng YW, Li CH, Lo YL, Kang JJ. Cholesterol-3-beta, 5-alpha, 6-beta-triol induced PI3K-Akt-eNOS-dependent cyclooxygenase-2 expression in endothelial cells. Toxicol Lett. 2009;190(2):172-8. [Crossref]  [PubMed] 
  47. Gueguen Y, Bertrand P, Ferrari L, Batt AM, Siest G. Control of apolipoprotein E secretion by 25-hydroxycholesterol and proinflammatory cytokines in the human astrocytoma cell line CCF-STTG1. Cell Biol Toxicol. 2001;17(3): 191-9. [Crossref]  [PubMed] 
  48. Kolsch H, Lutjohann D, Tulke A, Bjorkhem I, Rao ML. The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells. Brain Res. 1999;818(1):171-5. [Crossref] 
  49. Bretillon L, Siden A, Wahlund LO, Lutjohann D, Minthon L, Crisby M, et al. Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci Lett. 2000;293(2):87-90. [Crossref] 
  50. Lutjohann D, Papassotiropoulos A, Bjorkhem I, Locatelli S, Bagli M, Oehring RD, et al. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res. 2000;41(2): 195-8.
  51. Brown AJ, Leong S, Dean RT, Jessup W. 7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque. J Lipid Res. 1997;38 (9):1730-45.
  52. Liu Y, Hulten LM, Wiklund O. Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production. Arterioscler Thromb Vasc Biol. 1997;17(2):317-23. [Crossref]  [PubMed] 
  53. Gamba P, Guglielmotto M, Testa G, Monteleone D, Zerbinati C, Gargiulo S, et al. Up-regulation of β-amyloidogenesis in neuron-like human cells by both 24-and 27-hydroxycholesterol: protective effect of N-acetyl- cysteine. Aging Cell. 2014;13(3): 561-72. [Crossref]  [PubMed]  [PMC] 
  54. Lazo-de-la-Vega ML, Fernandez-Mejia C. Oxidative stress in diabetes mellitus and the role of vitamins with antioxidant actions. In Oxidative Stress and Chronic Degenerative Diseases-A Role for Antioxidants. InTech; 2013. [Crossref]  [PubMed] 
  55. Ferderbar S, Pereira EC, Apolinario E, Bertolami M, Faludi A, Monte O, et al. Cholesterol oxides as biomarkers of oxidative stress in type 1 and type 2 diabetes mellitus. Diabetes Metab Res Rev. 2007;23(1):35-42. [Crossref]  [PubMed] 
  56. Samadi A, Gurlek A, Sendur SN, Karahan S, Akbiyik F, Lay I. Oxysterol species: reliable markers of oxidative stress in diabetes mellitus. J Endocrinol Invest. 2019;42(1):7-17. [Crossref]  [PubMed] 4
  57. Yoon JH, Canbay AE, Werneburg NW, Lee SP, Gores GJ. Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: Implications for biliary tract carcinogenesis. Hepatology. 2004;39(3):732-8. [Crossref]  [PubMed] 
  58. Cao Y, Prescott SM. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol. 2002;190(3):279-86. [Crossref]  [PubMed] 
  59. Bischoff F, Rupp JJ. The production of a carcinogenic agent in the degradation of cholesterol to progesterone. Cancer Res. 1946;6(8): 403-9.
  60. Bischoff F. Cocarcinogenic activity of cholesterol oxidation products and sesame oil. J Natl Cancer Inst. 1957;19(5):977-87.
  61. Bischoff F. Carcinogenic effects of steroids. Advances in Lipid Research. Adv Lipid Res. 1969;7:165-244. [Crossref]  [PubMed] 
  62. Linseisen J, Wolfram G, Miller AB. Plasma 7β-hydroxycholesterol as a possible predictor of lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1630-7.
  63. Leonarduzzi G, Scavazza A, Biasi F, Chiarpotto E, Camandola S, Vogel S, et al. The lipid peroxidation end product 4-hydroxy-2, 3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J. 1997;11(11):851-7. [Crossref]  [PubMed] 
  64. Biasi F, Mascia C, Astegiano M, Chiarpotto E, Nano M, Vizio B, et al. Pro-oxidant and proapoptotic effects of cholesterol oxidation products on human colonic epithelial cells: a potential mechanism of inflammatory bowel disease progression. Free Radic Biol Med. 2009;47(12):1731-41. [Crossref]  [PubMed] 

.: Up To Date

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com